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Respiratory syncytial virus (RSV) is one of themost common etiological agents of childhood respiratory infections globally. Information
on seasonality of different antigenic groups is scarce. We aimed to describe the frequency, seasonality, and age of children infected
by RSV antigenic groups A (RSVA) and B (RSVB) among children with ARI in a 4-year period.
Children (6–23 months old) with respiratory infection for 7 days were enrolled in a prospective cross-sectional study, from
September, 2009 to October, 2013, in Salvador, in a tropical region of Brazil. Upon recruitment, demographic, clinical data, and
nasopharyngeal aspirates (NPA) were collected. A multiplex quantitative real-time polymerase chain reaction (RT-PCR) with a group-
speciﬁc primer and probeset for RSVA and RSVB was used. Seasonal distribution of infection by RSV different antigenic groups was
evaluated by Prais-Wisten regression.
Of 560 cases, the mean age was 11.4±4.5 months and there were 287 (51.3%) girls. Overall, RSV was detected in 139
(24.8%; 95% CI: 21.4%–28.5%) cases, RSVA in 74 (13.2%; 95% CI: 10.6%–16.2%) cases, and RSVB in 67 (12.0%; 95%
CI: 9.5%–14.9%) cases. Two (0.4%; 95% CI: 0.06%–1.2%) cases had coinfection. RSVA frequency was 9.6%, 18.4%,
21.6%, and 3.1% in 2010, 2011, 2012, and 2013, respectively. RSVB frequency was 19.2%, 0.7%, 1.4%, and 35.4% in
the same years. RSVA was more frequently found from August to January than February to July (18.2% vs. 6.4%, P<0.001).
RSVB was more frequently found (P<0.001) between March and June (36.0%) than July to October (1.0%) or November
to February (1.6%). RSVB infection showed seasonal distribution and positive association with humidity (P=0.02)
whereas RSVA did not. RSVA was more common among children ≥1-year-old (17.8% vs. 1.8%; P=0.02), as opposed to
RSVB (11.5% vs. 12.2%; P=0.8).
One quarter of patients had RSV infection. RSVA compromised more frequently children aged ≥1 year. RSVA predominated in
2011 and 2012 whereas RSVB predominated in 2010 and 2013. In regard to months, RSVA was more frequent from August to
January whereas RSVB was more often detected between March and June. Markedly different monthly as well as yearly patterns for
RSVA and RSVB reveal independent RSV antigenic groups’ epidemics.ditor: Krisztian Banyai.
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[11]1. Introduction
Acute respiratory infections (ARI) are the leading cause of
mortality in children less than 5 years old worldwide.[1] Viruses
are major contributors to the morbidity and mortality of ARI,
and respiratory syncytial virus (RSV) is one of the most common
etiological agents of respiratory infections such as bronchiolitis
and pneumonia.[2,3] It is estimated that nearly all children have
been infected by RSV by their second birthday.[4] Surveillance to
track RSV circulation is essential to establish effective preventive
measures to control RSV-associated severe ARI episodes.[5] RSV
incidence can be highly variable within countries and between
regions within a country depending on the level of seasonal
constraining.[6] Temperature, rainfall, and humidity have been
postulated to signiﬁcantly impact RSV seasonality[7] and
information on seasonality of different antigenic groups is scarce.
In this study, we aimed to describe the frequency, seasonality,
and age of children infected by RSV antigenic groups A (RSVA)
and B (RSVB) among children with ARI in a 4-year period.
2. Methods
2.1. Study design
This prospective cross-sectional study evaluated children with
ARI seen at the Pediatric Emergency Department of the Federal
University of Bahia Hospital, in Salvador, Northeastern Brazil,
between September, 2009 and October, 2013. This city is located
in a tropical region, the latitude being 12°5801600S, the longitude
38°3003900W, and the altitude 8m. Inclusion criteria comprised
children aged from 6 to 23 months with fever, sneeze, running
nose, nasal blockage, or cough for up to 7 days. Children
transferred from other hospitals or reporting a previous episode
of wheeze were excluded. Clinical and demographic data, as well
as ﬁndings on physical examination, were collected using a
standardized questionnaire.
2.2. Clinical deﬁnitions
Fever was deﬁned as axillary temperature >37.4 °C,[8] and
tachypnea as respiratory rate (RR) ≥50breaths/min among
children aged 6 to 11 months and RR ≥40breaths/min in children
from 12 months of age upwards.[9] Lower respiratory tract
infection (LRTI) was considered when the child had tachypnea
and/or any respiratory distress or crackles or wheezing.[10] Age
stratawere deﬁned as: under 1 yearwhen childrenwere364 days
old, and 1 year and above when children were ≥365 days old.
2.3. Laboratory procedures
Nasopharyngeal aspirate (NPA) samples were collected at study
enrollment, placed in Nuclisens Lysis Buffer (Biomeriux, Boxtel,
The Netherlands) and frozen at 70 °C. Total ribonucleic acid
was extracted using RNEasy (Qiagen’s, Hilden, Germany)
following manufacturer’s instructions. A multiplex quantitative
RT-PCRwith a group-speciﬁc primer and probeset for RSVA and
RSVB was used to identify the different antigenic groups of the2virus. The carboxyterminal region of the G protein was
ampliﬁed using the One-Step RT-PCR (Qiagen, Westburg, The
Netherlands). The RSVA forward and reverse primers, G267FW
and F164RV, respectively, and the RSVB forward and reverse
primers, BGF and BGR, respectively, were employed.[11]2.4. Meteorological data
Data about rainfall, relative humidity, air temperature, and hours
of sunshine were provided by the Institute of Environment and
Water Resources (INMET) in the State of Bahia with no missing
data over the months studied. The meteorological station that
provided the data is located approximately 2km away from the
Emergency Department where the study was carried out. Rainfall
was measured as daily precipitation, in millimeters, and was
analyzed as the total quantity of the month. Relative humidity
(%) and air temperature (°C) were measured three times per day,
and these were averaged monthly. Hours of sunshine were
measured as daily duration of sunshine, in hours, and were
calculated as monthly totals.
2.5. Statistical analysis
Sample size was estimated on an expected frequency of RSV
infection of 30%, total width of conﬁdence interval equal to 0.10,
and 99% conﬁdence level. Thus, the sample size was estimated at
558 cases. Categorical variables were presented as absolute
numbers (percentage) and continuous variables as the median
(interquartile range [IQR]). 95% Conﬁdence Interval (95% CI)
was calculated for the outcome variables. Categorical variables
were compared using the corrected chi-square or Fisher’s exact
test, as appropriate. The seasons and their corresponding months
were: summer (January, February, March), fall (April, May,
June), winter (July, August, September), and spring (October,
November, December). Time series analysis using Prais-Winsten
generalized linear regression (Y(i)=b0+b1∗X(i)+b2∗sin[2pX(i)/
12]+b3∗cos[2pX(i)/12]—in which “Y(i)" is the time series
measure for each moment “i”; “b0” is a constant; “b1” is the
trend indicator; “b2” and “b3” are seasonality indicators) was
used for seasonality detection of logarithmic transformed
monthly RSVA or RSVB number of cases. This regression model
detects monthly ﬂuctuations in the number of cases that are
consistent between years when the coefﬁcient “b2” or “b3” is
statistically different from zero. The association between
logarithmically transformed monthly RSVA or RSVB number
of cases with monthly values of meteorological factors was
evaluated by multiple regression using Prais-Winsten generalized
linear regression. Statistical tests were two-tailed, with a
signiﬁcance level of 0.05. The software Stata version 12
(StataCorp, USA) was used for these analyses.
2.6. Ethical approval
The study was approved by the Ethics Committee at the Federal
University of Bahia. Parents or legal guardians signed written
informed consent formsbefore enrollment of each studyparticipant.
Table 1
Distribution of respiratory syncytial virus antigenic group A and respiratory syncytial virus antigenic group B cases per year of study
among children with acute respiratory infection aged 6 to 23 months in a University Hospital in Salvador, Northeast Brazil, between
September, 2009 and October, 2013.
Study year
2009 (n=28) 2010 (n=156) 2011 (n=141) 2012 (n=139) 2013 (n=96)
RSVA – 15 (9.6%) 26 (18.4%) 30 (21.6%) 3 (3.1%)
RSVB – 30 (19.2%) 1 (0.7%) 2 (1.4%) 34 (35.4%)
Results presented as absolute number (percentage).
RSVA= respiratory syncytial virus antigenic group A, RSVB= respiratory syncytial virus antigenic group B.
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Among 1154 evaluated children, 504 (43.7%) reported at least 1
previous episode of wheezing, 16 (1.4%) did not have NPA
collected successfully, 11 (1.0%) came from other hospitals and
63 (5.4%) did not give consent. Thus, the study group comprised
560 cases. The mean age was 11.4±4.5 months and there were
287 (51.3%) girls. The most frequent complaints were cough
(86.8%), running nose (83.9%), fever (82.5%), and sneeze
(76.4%). On physical examination, the most frequent ﬁndings
were fever (40.3%), ronchi (37.0%), and tachypnea (23.6%).
Overall, 230 (41.1%) patients had lower respiratory tract
involvement, out of which 130 (57%) had tachypnea, 92 (40%)
presented wheezing, 51 (22.2%) presented crackles, and 32
(13.9%) presented thoracic recession. Forty-six (8.2%) children
attended day care centers.
Overall, RSV was detected in 139 (24.8%; 95% CI:
21.4%–28.5%) cases, RSVA in 74 (13.2%; 95% CI:
10.6%–16.2%) cases, and RSVB in 67 (12.0%; 95% CI:
9.5%–14.9%) cases. Two (0.4%; 95% CI: 0.06%–1.2%) were
coinfected. Table 1 shows the distribution of RSVA or B cases per
year of study. RSVA occurred more frequently in 2011 and 2012
whereas RSVB occurred more often in 2010 and 2013. RSVB
frequency demonstrated seasonal distribution (b2=0.44 and
b3=0.24; P=0.01) and was more frequent (P<0.001) in
March to June (36.0%) comparedwith July to October (1.0%) orTable 2
Monthly distribution of respiratory syncytial virus antigenic group A
children with acute respiratory infection aged 6 to 23 months in a Univ
2009 and October, 2013.
Months
2009 2010
RSVA RSVB Total
∗
RSVA RSVB Total
∗
RSVA
January — — — 0 0 6 4 (28.6)
February — — — 0 0 3 1 (7.7)
March — — — 0 11 (57.9) 19 1 (11.1)
April — — — 3 (23.1) 9 (69.2) 13 4 (28.6)
May — — — 0 7 (70.0) 10 2 (11.1)
June — — — 0 1 (33.3) 3 1 (7.7)
July — — — 0 0 3 0
August — — — 0 0 32 0
September 0 0 8 3 (15.8) 1 (5.3) 19 0
October 0 0 4 3 (21.4) 1 (7.1) 14 1 (25.0)
November 0 0 6 4 (17.4) 0 23 7 (100)
December 0 0 10 2 (18.2) 0 11 5 (33.3)
Results presented as absolute number (percentage).
RSVA= respiratory syncytial virus antigenic group A; RSVB= respiratory syncytial virus antigenic group
∗
Total number of cases recruited per each month of study recruitment.
3November to February (1.6%). Conversely, RSVA was more
frequent fromAugust to January compared with February to July
(18.2% vs. 6.4%, P<0.001). RSVA cases were distributed in
several distinct months in different years. The RSVA seasonal
pattern was not statistically signiﬁcant on a monthly basis.
Table 2 shows the monthly distribution of RSVA and RSVB
during the study period. It is possible to verify that there was an
alternating pattern between RSVA and RSVB cases.
There was a positive association between monthly RSVB
number of cases and humidity (multiple regression coefﬁcient for
humidity=0.10; P=0.02). There was no association between
RSVA frequency and meteorological factors. Figure 1 shows the
monthly distribution of mean relative humidity and of RSVA and
RSVB number of cases during the study period. All meteorologi-
cal factors showed seasonal distribution (Fig. 2).
Table 3 shows that RSVA was more frequent among children
aged1 year and above comparedwith younger children (17.8%vs.
10.8%; P=0.02). No difference was found in the distribution of
RSVB in regard to age strata (11.5% vs. 12.2%; P=0.8). RSVA
was similarly found among patients with or without their lower
respiratory tract being compromised (12.6% vs. 13.6%; P=0.7).
Likewise, RSVB was similarly distributed among these subgroups
(12.2% vs. 11.8%; P=0.9). Table 4 compares the frequency of
symptoms, signs, and day care center attendance between cases
with or without RSV detected. No difference was found.and respiratory syncytial virus antigenic group B cases among
ersity Hospital in Salvador, Northeast Brazil, between September,
Year
2011 2012 2013
RSVB Total
∗
RSVA RSVB Total
∗
RSVA RSVB Total
∗
0 14 4 (28.6) 1 (7.1) 14 0 0 18
0 13 0 0 4 0 2 (16.7) 12
0 9 0 1 (12.5) 8 0 7 (63.6) 11
0 14 0 0 7 3 (13.6) 16 (72.7) 22
1 (5.6) 18 0 0 6 0 7 (87.5) 8
0 13 0 0 8 0 2 (66.7) 3
0 8 0 0 14 0 0 6
0 14 8 (53.3) 0 15 0 0 7
0 12 5 (31.3) 0 16 0 0 8
0 4 6 (30.0) 0 20 0 0 1
0 7 4 (26.7) 0 15 — — —
0 15 3 (25.0) 0 12 — — —
B.
Figure 1. Monthly distribution of respiratory syncytial virus antigenic group A and respiratory syncytial virus antigenic group B cases among total number of children
with acute respiratory infection aged 6 to 23 months and of mean relative humidity (%) in Salvador, Northeastern Brazil, between September, 2009 and October,
2013.
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RSVB infection showed seasonal distribution with higher
frequency in late summer and fall and had positive correlation
with humidity. In contrast, RSVA infection did not show a
consistent seasonal pattern throughout the 4 years study. That is,
RSVA and RSVB infection occurred in different months in this
tropical city. To the best of our knowledge, this study is the ﬁrst to
demonstrate that infection by the different antigenic groups
RSVA or RSVB occurs in different months during the year.
Our study has limitations. It was conducted in a single center.
Similar studies enrolling children at multiple centers throughout
the full 12 calendar months and for at least 4 years are necessary
in order to reach deﬁnitive conclusions about the different
seasonal characteristics of RSVA and RSVB.Moreover, genotype
data on the different circulating subtypes are not available.
Additionally, children aged under 6 months were not included.
However, the option to study children aged ≥6 months was due
to the fact that these children usually go out and are in contact
with people living in the community. Breastfeeding is very
frequent in our country during the ﬁrst 6 months of life as
maternity leave lasts for 6 months after delivery. Therefore,
children aged <6 months are less exposed than those aged ≥6
months.
RSV infection distribution has been recently addressed
between April 2012 and March 2013 among children younger
than 2 years hospitalized with LRTI in 4 cities in Northeastern
Brazil; however, the infection distribution of the different
antigenic groups A and B was not assessed.[12] It has been
shown that the activity of RSVA and B usually occurs in
association with the rainy season and there is evidence that
temperature and associated factors, primarily humidity, are
important factors in the seasonality.[7] These factors can inﬂuence
the fusion of viruses with the cellular membranes allowing for cell
entry and replication. Humidity strongly inﬂuences virus stability
and transmissibility.[13] Herein, infection by RSVB was positively
associatedwith humidity. Different studies conducted in Belgium,4Finland, Pakistan, the UK, and Uruguay have presented the
cocirculation of RSVA and B in the same period of the
year.[11,14–16] However, in our study, which lasted 4 years and
was conducted in the tropical city of Salvador, Brazil, the
monthly circulation of RSVA and B was markedly different.
There were different periods of high humidity during the 4 years
studied (Fig. 1). Herein, RSVA and B circulated not only in
differentmonths but also in different years with alternating yearly
patterns (Table 1). That is why RSVA and RSVB coinfection rate
was very low (0.4%). The pattern of 2 to 4 consecutive years of
group A predominance followed by a single intervening year in
which group B is dominant was reported in countries like
Uruguay and Finland.[14,15] Competitive relationship and cross-
immunity between these antigenic groups have been reported in
the population. Following infection, individuals gain transient
immunity which average duration is 2 years.[15]
Among our cases, overall, RSV was found in 24.8%. A study
conducted in Southeastern Brazil reported that 27.4% of children
aged less than 2 years with ARI had RSV.[2] Other studies
conducted in the Northern and Southeastern Brazil presented
similar frequencies in children aged less than 2 to 3 years with
ARI.[17,18] One study carried out in another city in Northeastern
Brazil showed that 48% of the children had RSV. This ﬁnding
may be attributed to the study period, as the studywas carried out
only in the rainy season.[19] It has been shown that RSV
frequencies depend on local climate and can vary between 27.8%
and 37.9% in temperate, subtropical, and tropical countries, in
the same age population.[6,20–23] We showed that there was no
difference between the overall RSV groups frequency (13.2%
vs.12.0%). However, RSVA is usually predominant in the
majority of the studies involving children with ARI.[12,14,20,24]
RSVA predominance has been attributed to the higher variability
among these group strains and normally the dominant strain has
a mechanism for frequent reinfections by evasion of immunity
induced by previous strains.[25] This absence of RSVA predomi-
nance in our study may be explained by the unique total length of
Figure 2. Seasonal distribution of meteorological factors during the study period in Salvador, Northeastern Brazil.
Bouzas et al. Medicine (2016) 95:41 www.md-journal.comthe study (4 years), of which 2 years were dominated by RSVA
and 2 years were dominated by RSVB.
We found that RSVA was more common among children aged
1 year and above. A study conducted in 7 different countries
presented that, across all countries, RSVA was more frequent in
children aged 36 to 59 months whereas the lowest frequency was
detected in the 6 to 11 months old group. In that study, children
between 6 months and 10 years of age were included.[26] In
general, it has been described that RSV is frequent in children
under 1 year of age. However, the distribution of different
antigenic groups (A and B) is not commonly reported.5Almost half of the children presented lower respiratory tract
involvement (41.1%) and the frequency of RSVA and B was not
different among childrenwith or without such involvement. It has
been reported that children with RSV infection present frequent
involvement of the lower respiratory tract.[27,28] Our samples
were collected from children in the emergency department
irrespective of severity. Moreover, the etiological diagnoses were
performed with very sensitive methods. That is, this study
included primarily children with ARI (not only LRTI) and RSV
was searched for by very sensitive tests. This strategy allowed us
to detect RSV among children with ARI, without predeﬁned
Table 3
Comparison of different respiratory syncytial virus antigenic
groups infection frequency among children with acute respiratory
infection aged 6 to 11 months or 12 to 23 months.
Age strata
RSV antigenic group 6–11 mo 12–23 mo P
RSVA 40 (10.8%) 34 (17.8%) 0.02
RSVB 45 (12.2%) 22 (11.5%) 0.8
Total number of cases 369 191
Results presented as absolute number (percentage).
RSVA= respiratory syncytial virus antigenic group A, RSVB= respiratory syncytial virus antigenic
group B.
Bouzas et al. Medicine (2016) 95:41 Medicineselection in favor of cases with more severe presentation (with
lower respiratory tract involvement).
The monthly and yearly distribution of infection by RSV is
usually addressed during fall and winter months, all over the
world. As such, the distribution of the cases infected by RSV is
known to occur during the RSV season. Based on these ﬁndings,
recommendations for immunoprophylaxis for high risk groups of
severe disease have been made as the RSV distribution along the
year impacts on the immunoprophylaxis calendar with mono-
clonal antibody. In Brazil, palivizumab applications are recom-
mended between February and July in the Northeastern
region.[29] This practice is based on the assumption that RSV
circulates between March and July in these regions. This routine
is inﬂuenced by guidelines developed and implemented in
countries in temperate regions.[30] However, we demonstrated
that RSV infection occurs not only during the expected RSV
season. Indeed, RSVB infection occurs during the RSV season but
this is not the case for RSVA. Taking into account that our results
were provided in a 4-year period of data collection, guidelines for
speciﬁc immunoprophylaxis against RSV should be reviewed in
the tropical region. In the current form, prophylaxis is
appropriate for infection by RSVB but not for infection by
RSVA. Furthermore, our ﬁndings highlight the necessity toTable 4
Comparison of the frequency of symptoms, signs, and day care
center attendance between children with acute respiratory
infection with or without respiratory syncytial virus detected in
nasopharyngeal aspirates.
Characteristics
Respiratory syncytial virus
PYes (n=139) No (n=421)
Symptoms
Cough 121 (87.1) 365 (86.7) 0.9
Running nose 123 (88.5) 347 (82.4) 0.09
Fever 111 (79.9) 350 (83.3) 0.4
Sneeze 112 (80.6) 316 (75.1) 0.2
Signs
Fever 52 (37.4) 169/410 (41.2)† 0.4
Ronchi 50 (36.0) 157 (37.3) 0.8
Tachypnea 36/135 (26.7)
∗
94/416 (22.6)† 0.3
Wheezing 18 (12.9) 74 (17.6) 0.2
Crackles 15 (10.8) 36 (8.6) 0.4
Thoracic recession 9 (6.5) 23 (5.5) 0.7
LRTI 56 (40.3) 174 (41.3) 0.8
Day care center attendance 7 (5.0) 39 (9.3) 0.1
Results presented as absolute number (percentage).
LRTI= lower respiratory tract infection.
∗
The denominator was not 139 due to missing data.
† The denominator was not 421 due to missing data.
6implement RSV vaccine, which should be effective against both
antigenic groups A and B, as vaccination confers protection for
longer periods of time than the current available passive
immunization (palivizumab). Further studies conducted in tropical
regions with data collection during the whole year calendar for at
least 4 years would be highly appreciated. The duration of our
study was fundamental in order to ﬁnd our results.5. Conclusion
We conclude that seasonality was markedly different between
distinct antigenic groups, when RSVA presented a non-seasonal
pattern. A positive association between RSVB and humidity was
found. One quarter of the patients had RSV detected, similar to
other studies in the same region. RSVA compromised more
frequently children aged 1 year and above. Guidelines for speciﬁc
immunoprophyl axis against RSV should be reviewed in the
tropical region as the circulation of RSV is supposedly at the same
time among otherwise healthy children as among high risk
groups of severe RSV infection.Acknowledgments
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